Cargando…

Correlation between dietary inflammation and mortality among hyperlipidemics

BACKGROUND AND OBJECTIVE: Although the the Dietary Inflammatory Index (DII) serves to be one of the reliable indicator for hyperlipidaemia, there is still uncertainty about its relationship to prognosis in the hyperlipidaemic population. In current study, the DII levels were analyzed in relation to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lili, Liu, Tao, Zhang, Qingdui, Wang, Lele, Zhou, Qiang, Wang, Jing, Miao, Hao, Hao, Ji, Qi, Chunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683303/
https://www.ncbi.nlm.nih.gov/pubmed/38017484
http://dx.doi.org/10.1186/s12944-023-01975-0
_version_ 1785151165719117824
author Wang, Lili
Liu, Tao
Zhang, Qingdui
Wang, Lele
Zhou, Qiang
Wang, Jing
Miao, Hao
Hao, Ji
Qi, Chunmei
author_facet Wang, Lili
Liu, Tao
Zhang, Qingdui
Wang, Lele
Zhou, Qiang
Wang, Jing
Miao, Hao
Hao, Ji
Qi, Chunmei
author_sort Wang, Lili
collection PubMed
description BACKGROUND AND OBJECTIVE: Although the the Dietary Inflammatory Index (DII) serves to be one of the reliable indicator for hyperlipidaemia, there is still uncertainty about its relationship to prognosis in the hyperlipidaemic population. In current study, the DII levels were analyzed in relation to the mortality risk among among the hyperlipidaemic individuals with the aim of determining any prospective correlation. METHODS: 14,460 subjects with hyperlipidaemia from the 10-year (2001–2010) National Health and Nutrition Examination Survey (NHANES) were chosen for this study. The endpoint event for follow-up was all-cause mortality, and subjects were tracked for up to December 31, 2019, or death, whichever occurred first. The tertiles of the DII levels were utilized for categorizing the study population into three groups. Survival curves, Cox proportional hazards regression models, restricted cubic spline (RCS), subgroup and interaction analyses, and sensitivity analyses were employed sequentially for the purpose of evaluating the association of the DII with mortality. RESULTS: 3170 (21.92%) all-cause deaths were recorded during an average 148-month follow-up period. Kaplan-Meier survival curves indicated that the survival rate of participants divided into the low DII group was substantially improved compared to that of those in the higher DII group (log-rank P < 0.001). After controlling for confounders, higher levels of DII were observed to be meaningfully linked to an elevated risk of death, no matter whether DII was specified for the continuous (hazard ratio (HR): 1.06; 95% confidence interval (CI): 1.04–1.08) or the categorical variable (HR: 1.22; 95% CI: 1.11–1.33). The DII and mortality displayed a linear association, according to the RCS. Stratified and sensitivity analyses reinforced the proof that these findings were reliable. CONCLUSION: Among patients with hyperlipidaemia, the risk of death was positively and linearly linked with DII levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01975-0.
format Online
Article
Text
id pubmed-10683303
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106833032023-11-30 Correlation between dietary inflammation and mortality among hyperlipidemics Wang, Lili Liu, Tao Zhang, Qingdui Wang, Lele Zhou, Qiang Wang, Jing Miao, Hao Hao, Ji Qi, Chunmei Lipids Health Dis Research BACKGROUND AND OBJECTIVE: Although the the Dietary Inflammatory Index (DII) serves to be one of the reliable indicator for hyperlipidaemia, there is still uncertainty about its relationship to prognosis in the hyperlipidaemic population. In current study, the DII levels were analyzed in relation to the mortality risk among among the hyperlipidaemic individuals with the aim of determining any prospective correlation. METHODS: 14,460 subjects with hyperlipidaemia from the 10-year (2001–2010) National Health and Nutrition Examination Survey (NHANES) were chosen for this study. The endpoint event for follow-up was all-cause mortality, and subjects were tracked for up to December 31, 2019, or death, whichever occurred first. The tertiles of the DII levels were utilized for categorizing the study population into three groups. Survival curves, Cox proportional hazards regression models, restricted cubic spline (RCS), subgroup and interaction analyses, and sensitivity analyses were employed sequentially for the purpose of evaluating the association of the DII with mortality. RESULTS: 3170 (21.92%) all-cause deaths were recorded during an average 148-month follow-up period. Kaplan-Meier survival curves indicated that the survival rate of participants divided into the low DII group was substantially improved compared to that of those in the higher DII group (log-rank P < 0.001). After controlling for confounders, higher levels of DII were observed to be meaningfully linked to an elevated risk of death, no matter whether DII was specified for the continuous (hazard ratio (HR): 1.06; 95% confidence interval (CI): 1.04–1.08) or the categorical variable (HR: 1.22; 95% CI: 1.11–1.33). The DII and mortality displayed a linear association, according to the RCS. Stratified and sensitivity analyses reinforced the proof that these findings were reliable. CONCLUSION: Among patients with hyperlipidaemia, the risk of death was positively and linearly linked with DII levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01975-0. BioMed Central 2023-11-28 /pmc/articles/PMC10683303/ /pubmed/38017484 http://dx.doi.org/10.1186/s12944-023-01975-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Lili
Liu, Tao
Zhang, Qingdui
Wang, Lele
Zhou, Qiang
Wang, Jing
Miao, Hao
Hao, Ji
Qi, Chunmei
Correlation between dietary inflammation and mortality among hyperlipidemics
title Correlation between dietary inflammation and mortality among hyperlipidemics
title_full Correlation between dietary inflammation and mortality among hyperlipidemics
title_fullStr Correlation between dietary inflammation and mortality among hyperlipidemics
title_full_unstemmed Correlation between dietary inflammation and mortality among hyperlipidemics
title_short Correlation between dietary inflammation and mortality among hyperlipidemics
title_sort correlation between dietary inflammation and mortality among hyperlipidemics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683303/
https://www.ncbi.nlm.nih.gov/pubmed/38017484
http://dx.doi.org/10.1186/s12944-023-01975-0
work_keys_str_mv AT wanglili correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT liutao correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT zhangqingdui correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT wanglele correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT zhouqiang correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT wangjing correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT miaohao correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT haoji correlationbetweendietaryinflammationandmortalityamonghyperlipidemics
AT qichunmei correlationbetweendietaryinflammationandmortalityamonghyperlipidemics